Advertisement
Loading...

AbbVie Inc.

ABBV•NYSE
Healthcare
Drug Manufacturers - General
$210.39
$-0.38(-0.18%)
U.S. Market opens in 27h 4m

AbbVie Inc. (ABBV) Stock Overview

Explore AbbVie Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap371.8B
P/E Ratio102.75
EPS (TTM)$2.04
ROE0.68%
Fundamental Analysis

AI Price Forecasts

1 Month$225.19
3 Months$221.65
1 Year Target$237.10

ABBV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of AbbVie Inc. (ABBV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.82, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $237.10.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 102.75 and a market capitalization of 371.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.17%
5-Day Change
4.21%
1-Month Change
0.96%
3-Month Change
-9.11%
6-Month Change
-9.44%
Year-to-Date (YTD) Change
-7.91%
1-Year Change
15.82%
3-Year Change
43.54%
5-Year Change
80.02%
All-Time (Max) Change
501.20%

Contact Information

https://www.abbvie.com
847 932 7900
1 North Waukegan Road, North Chicago, IL, 60064-6400

Company Facts

55,000 Employees
IPO DateJan 2, 2013
CountryUS
Actively Trading

Frequently Asked Questions